Whipplewood Advisors, LLC Glaukos Corp Transaction History
Whipplewood Advisors, LLC
- $169 Billion
- Q1 2025
A detailed history of Whipplewood Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 284 shares of GKOS stock, worth $25,077. This represents 0.01% of its overall portfolio holdings.
Number of Shares
284
Previous 7
3957.14%
Holding current value
$25,077
Previous $1.05 Million
1606.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GKOS
# of Institutions
350Shares Held
48MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$710 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$528 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$182 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$170 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$129 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.2B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...